Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 345.00
+25.00 (7.81%)
Aug 28, 2025, 5:15 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 16.31 million as of August 28, 2025. Its market cap has decreased by -8.96% in one year.
Market Cap
16.31M
Enterprise Value
18.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
345.00
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 16.31M, an increase of 52.69%. That is a compound annual growth rate of 5.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 16.31M | 14.91% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | 41.85M | 494.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.59B |
| GSK plc | 59.62B |
| Haleon | 32.68B |
| Smith & Nephew | 12.05B |
| ConvaTec Group | 4.96B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.00B |